Evidence map›Paper›PMID 37965335›Full record

ArticleFrontiers in immunology2023

The slan antigen identifies the prototypical non-classical CD16

Nicola Tamassia, Francisco Bianchetto-Aguilera, Sara Gasperini, Alessio Grimaldi, Claudia Montaldo, Federica Calzetti, Elisa Gardiman, Ilaria Signoretto, Monica Castellucci, Vincenzo Barnaba and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Regulatory Effects of CD14Journal of immunology research · 2026
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Nicola Tamassia *Department of Medicine, Section of General Pathology, University of Verona, Verona, Italy.
Francisco Bianchetto-Aguilera *Department of Medicine, Section of General Pathology, University of Verona, Verona, Italy.
Sara GasperiniDepartment of Medicine, Section of General Pathology, University of Verona, Verona, Italy.
Alessio GrimaldiDepartment of Internal Clinical Sciences, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Claudia MontaldoNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy.
Federica CalzettiDepartment of Medicine, Section of General Pathology, University of Verona, Verona, Italy.
Elisa GardimanDepartment of Medicine, Section of General Pathology, University of Verona, Verona, Italy.
Ilaria SignorettoDepartment of Medicine, Section of General Pathology, University of Verona, Verona, Italy.
Monica CastellucciCentro Piattaforme Tecnologiche, University of Verona, Verona, Italy.
Vincenzo BarnabaDepartment of Internal Clinical Sciences, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Marco TripodiDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Marco Antonio CassatellaDepartment of Medicine, Section of General Pathology, University of Verona, Verona, Italy.
University of Verona · ITSapienza University of Rome · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · IT

Funding

Cancer Research UK 26813
6 · The paper itself

Abstract

Introduction: Peripheral monocytes in humans are conventionally divided into classical (CL, CD14 Methods: We analyzed transcriptome (by bulk and single cell RNA-seq), proteome, cell surface markers and production of discrete cytokines by peripheral slan Results: By bulk RNA-seq and proteomic analysis, we found that slan Conclusion: In addition to comparatively characterize total NC-, slan

Indexed as

MonocytesProteomicsHumansLeukocytes, Mononuclearclassical/non-classical monocytesproteomicsscRNA-seqslan+-monocytestranscriptomics

Identifiers

PMID37965335
PMCPMC10641684
OpenAlexW4387968415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.